News Releases

28 Jul '20
-- Researchers presented new preclinical data on atuzaginstat   and the potential impact on cardiovascular disease and AD-associated neurodegeneration in two poster presentations at AAIC 2020 -- Cortexyme also presented phase 1b clinical data demonstrating atuzaginstat‘s   therapeutic potential in
Displaying 1 - 10 of 26